Do Patient Characteristics Moderate the Effect of Extended-Release Naltrexone (XR-NTX) for Opioid Use Disorder?

BACKGROUND: Extended release naltrexone (XR-NTX) injected intramuscularly monthly has been shown to reduce relapse in persons with opioid use disorder. Baseline factors, including patients’ demographics, comorbidities and lifestyle, may help identify patients who will benefit most or least from XR-N...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Subst Abuse Treat
Hlavní autoři: Friedmann, Peter D., Wilson, Donna, Nunes, Edward V., Hoskinson, Randall, Lee, Joshua D., Gordon, Michael, Murphy, Sean M., Bonnie, Richard J., Chen, Donna T., Boney, Tamara Y., O’Brien, Charles P.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5565721/
https://ncbi.nlm.nih.gov/pubmed/28236511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2017.01.018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky